---
figid: PMC5713689__dddt-11-3367Fig3
figtitle: 'Signal pathway of the immune inhibitory receptors.Notes: PD-1 crosslinks
  the TCR and recruits the SHP-2, which can dephosphorylate the ZAP-70 to prevent
  the SLP-76 and LAT from being phosphorylated'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5713689
filename: dddt-11-3367Fig3.jpg
figlink: /pmc/articles/PMC5713689/figure/f3-dddt-11-3367/
number: F3
caption: 'Signal pathway of the immune inhibitory receptors.Notes: PD-1 crosslinks
  the TCR and recruits the SHP-2, which can dephosphorylate the ZAP-70 to prevent
  the SLP-76 and LAT from being phosphorylated. PD-1 can also restrain the CK2 to
  stop the phosphorylation of PTEN for inhibiting the PI3K/Akt pathway. FOXP3 can
  be acetylized by TIP60 and then form a complex with H1.5, which can replace AP-1
  in NFAT/AP-1 to downregulate expression of cytokines. CTLA-4 can recruit SHP-2,
  which can dephosphorylate ZAP-70 and can inhibit the effect of Erk and block the
  activation signal conducted by the Erk/MEK pathway. LAG-3 combines with the CD3/TCR
  and then downregulates signal transduction such as inhibiting PLC-γ, changing calcium
  ionic flow, and downregulating cytokine expression. TIGIT owns ITT-like motif of
  which Tyr-225 can be phosphorylated. It can recruit adapter protein β-arrestin 2
  and then recruit SHIP1, which can block the ubiquitination of TRAF6 to restrain
  activation of IκBα factor, leading to the failure of NF-κB signal pathways and low
  cytokine expression.Abbreviations: AP-1, activated protein-1; Akt, protein kinase
  B; CK2, casein kinase-2; CTLA-4, cytotoxic T-lymphocyte-associated antigen-4; FOXP3,
  Forkhead box protein-3; LAG-3, lymphocyte activation gene-3; MEK, mitogen-activated
  protein kinase-extracellular signal-related kinase kinase; NF-κB, nuclear factor
  of kappa light polypeptide gene enhancer in B cells; NFAT, nuclear factor of activated
  T cells; P, phosphate; PD-1, programmed death-1; PD-L1, programmed death ligand
  1; PLC-γ, phospholipase C gamma; PTEN, phosphatase and tensin homolog deleted on
  chromosome ten; Ras, Ras protein/small G protein; SHIP1, Scy homology 2 domain-containing
  inositol phosphatase-1; SHP-2, Scy homology 2 domain-containing protein tyrosine
  phosphatase-2; TCR, T-cell receptor; TIGIT, T-cell immunoglobulin and ITIM domain;
  TIP60, Tat-interacting protein (60 kDa); TRAF6, tumor necrosis factor receptor-associated
  factor 6; ZAP-70, zeta-chain-associated protein kinase-70.'
papertitle: The coexpression of multi-immune inhibitory receptors on T lymphocytes
  in primary non-small-cell lung cancer.
reftext: Wenjie Guo, et al. Drug Des Devel Ther. 2017;11:3367-3376.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9557624
figid_alias: PMC5713689__F3
figtype: Figure
redirect_from: /figures/PMC5713689__F3
ndex: f499a427-dee8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5713689__dddt-11-3367Fig3.html
  '@type': Dataset
  description: 'Signal pathway of the immune inhibitory receptors.Notes: PD-1 crosslinks
    the TCR and recruits the SHP-2, which can dephosphorylate the ZAP-70 to prevent
    the SLP-76 and LAT from being phosphorylated. PD-1 can also restrain the CK2 to
    stop the phosphorylation of PTEN for inhibiting the PI3K/Akt pathway. FOXP3 can
    be acetylized by TIP60 and then form a complex with H1.5, which can replace AP-1
    in NFAT/AP-1 to downregulate expression of cytokines. CTLA-4 can recruit SHP-2,
    which can dephosphorylate ZAP-70 and can inhibit the effect of Erk and block the
    activation signal conducted by the Erk/MEK pathway. LAG-3 combines with the CD3/TCR
    and then downregulates signal transduction such as inhibiting PLC-γ, changing
    calcium ionic flow, and downregulating cytokine expression. TIGIT owns ITT-like
    motif of which Tyr-225 can be phosphorylated. It can recruit adapter protein β-arrestin
    2 and then recruit SHIP1, which can block the ubiquitination of TRAF6 to restrain
    activation of IκBα factor, leading to the failure of NF-κB signal pathways and
    low cytokine expression.Abbreviations: AP-1, activated protein-1; Akt, protein
    kinase B; CK2, casein kinase-2; CTLA-4, cytotoxic T-lymphocyte-associated antigen-4;
    FOXP3, Forkhead box protein-3; LAG-3, lymphocyte activation gene-3; MEK, mitogen-activated
    protein kinase-extracellular signal-related kinase kinase; NF-κB, nuclear factor
    of kappa light polypeptide gene enhancer in B cells; NFAT, nuclear factor of activated
    T cells; P, phosphate; PD-1, programmed death-1; PD-L1, programmed death ligand
    1; PLC-γ, phospholipase C gamma; PTEN, phosphatase and tensin homolog deleted
    on chromosome ten; Ras, Ras protein/small G protein; SHIP1, Scy homology 2 domain-containing
    inositol phosphatase-1; SHP-2, Scy homology 2 domain-containing protein tyrosine
    phosphatase-2; TCR, T-cell receptor; TIGIT, T-cell immunoglobulin and ITIM domain;
    TIP60, Tat-interacting protein (60 kDa); TRAF6, tumor necrosis factor receptor-associated
    factor 6; ZAP-70, zeta-chain-associated protein kinase-70.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TIGIT
  - CTLA4
  - LAG3
  - CD247
  - CD3D
  - CD3E
  - CD3G
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - PTPN11
  - LCK
  - ZAP70
  - FOXP3
  - KAT5
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - LCP2
  - LAT
  - ORC3
  - SPNS1
  - RASGRP1
  - PTEN
  - TRAF6
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - AKT1
  - AKT2
  - AKT3
  - H1-5
  - NFKBIA
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - MTOR
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - PTPA
  - INPP5D
  - Glucose
  - Tyr
  - Cancer
---
